Christopher Kenneth Savile - Net Worth and Insider Trading
Christopher Kenneth Savile Net Worth
The estimated net worth of Christopher Kenneth Savile is at least $129,420 dollars as of 2024-11-08. Christopher Kenneth Savile is the Director, Senior Officer of Willow Biosciences Inc and owns about 1,362,313 shares of Willow Biosciences Inc (TSX:WLLW) stock worth over $129,420. Details can be seen in Christopher Kenneth Savile's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher Kenneth Savile has not made any transactions after 2024-09-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher Kenneth Savile
Christopher Kenneth Savile Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher Kenneth Savile owns 1 companies in total, including Willow Biosciences Inc (TSX:WLLW) .
Click here to see the complete history of Christopher Kenneth Savile’s form 4 insider trades.
Insider Ownership Summary of Christopher Kenneth Savile
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:WLLW | Willow Biosciences Inc | 2024-09-05 | Director & Senior Officer |
Christopher Kenneth Savile Latest Holdings Summary
Christopher Kenneth Savile currently owns a total of 1 stock. Christopher Kenneth Savile owns 1,362,313 shares of Willow Biosciences Inc (TSX:WLLW) as of September 5, 2024, with a value of $129,420.
Latest Holdings of Christopher Kenneth Savile
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:WLLW | Willow Biosciences Inc | 2024-09-05 | 1,362,313 | 0.10 | 129,420 |
Holding Weightings of Christopher Kenneth Savile
Christopher Kenneth Savile Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher Kenneth Savile has made a total of 2 transactions in Willow Biosciences Inc (TSX:WLLW) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Willow Biosciences Inc is the acquisition of 50,000 shares on September 5, 2024, which cost Christopher Kenneth Savile around $5,000.
Insider Trading History of Christopher Kenneth Savile
- 1
Christopher Kenneth Savile Trading Performance
GuruFocus tracks the stock performance after each of Christopher Kenneth Savile's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher Kenneth Savile is %. GuruFocus also compares Christopher Kenneth Savile's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher Kenneth Savile within 3 months outperforms times out of transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christopher Kenneth Savile's insider trading performs compared to the benchmark.
Performance of Christopher Kenneth Savile
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -9.52 |  | | | | |
| Relative Return to S&P 500(%) | -14.02 | | | | | |
Christopher Kenneth Savile Ownership Network
Ownership Network List of Christopher Kenneth Savile
Ownership Network Relation of Christopher Kenneth Savile
Christopher Kenneth Savile Owned Company Details
What does Willow Biosciences Inc do?
Who are the key executives at Willow Biosciences Inc?
Christopher Kenneth Savile is the Director & Senior Officer of Willow Biosciences Inc. Other key executives at Willow Biosciences Inc include Senior Officer Travis Doupe , Director & Senior Officer Trevor Anthony Peters , and Senior Officer Troy Tapan Talkkari .
Willow Biosciences Inc (TSX:WLLW) Insider Trades Summary
Over the past 18 months, Christopher Kenneth Savile made 1 insider transaction in Willow Biosciences Inc (TSX:WLLW) with a net purchase of 50,000. Other recent insider transactions involving Willow Biosciences Inc (TSX:WLLW) include a net purchase of 70,000 shares made by Patricia Ranija Choudhary , a net purchase of 49,500 shares made by Travis Doupe ,
In summary, during the past 3 months, insiders sold 0 shares of Willow Biosciences Inc (TSX:WLLW) in total and bought 99,500 shares, with a net purchase of 99,500 shares. During the past 18 months, 0 shares of Willow Biosciences Inc (TSX:WLLW) were sold and 169,500 shares were bought by its insiders, resulting in a net purchase of 169,500 shares.
Willow Biosciences Inc (TSX:WLLW)'s detailed insider trading history can be found in Insider Trading Tracker table.
Willow Biosciences Inc Insider Transactions
Christopher Kenneth Savile Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher Kenneth Savile. Currently GuruFocus does not have mailing address information for Christopher Kenneth Savile.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
